Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Artery Disease | 34 | 2023 | 6416 | 3.190 |
Why?
|
Coronary Angiography | 28 | 2023 | 4560 | 2.470 |
Why?
|
Plaque, Atherosclerotic | 10 | 2023 | 1483 | 1.740 |
Why?
|
Chest Pain | 10 | 2023 | 1112 | 1.360 |
Why?
|
Coronary Vessels | 9 | 2023 | 3097 | 1.230 |
Why?
|
Aortic Valve Stenosis | 9 | 2018 | 1930 | 0.980 |
Why?
|
Heart Valve Prosthesis Implantation | 10 | 2022 | 1515 | 0.850 |
Why?
|
Cardiac Volume | 2 | 2021 | 210 | 0.770 |
Why?
|
Cardiac-Gated Imaging Techniques | 9 | 2019 | 143 | 0.770 |
Why?
|
Aortic Valve | 8 | 2015 | 1900 | 0.760 |
Why?
|
Predictive Value of Tests | 25 | 2023 | 15036 | 0.730 |
Why?
|
Asymptomatic Diseases | 3 | 2021 | 549 | 0.710 |
Why?
|
Tomography, X-Ray Computed | 17 | 2023 | 20055 | 0.700 |
Why?
|
Mediastinitis | 1 | 2019 | 48 | 0.680 |
Why?
|
Sternotomy | 1 | 2019 | 121 | 0.620 |
Why?
|
Psoas Muscles | 1 | 2018 | 71 | 0.610 |
Why?
|
HIV Infections | 9 | 2023 | 16764 | 0.560 |
Why?
|
Atherosclerosis | 5 | 2023 | 3401 | 0.550 |
Why?
|
Pericardium | 1 | 2020 | 665 | 0.540 |
Why?
|
Calcinosis | 3 | 2023 | 1493 | 0.520 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 4 | 2019 | 1185 | 0.520 |
Why?
|
Calcium | 6 | 2023 | 5742 | 0.510 |
Why?
|
Subcutaneous Fat | 1 | 2018 | 392 | 0.500 |
Why?
|
Heart Valve Prosthesis | 5 | 2020 | 1479 | 0.490 |
Why?
|
Radiology Information Systems | 1 | 2017 | 523 | 0.440 |
Why?
|
Intra-Abdominal Fat | 1 | 2018 | 590 | 0.440 |
Why?
|
Coronary Stenosis | 4 | 2022 | 836 | 0.400 |
Why?
|
Pulmonary Embolism | 1 | 2023 | 2365 | 0.360 |
Why?
|
Surgical Wound Infection | 1 | 2019 | 1530 | 0.340 |
Why?
|
Anti-Retroviral Agents | 1 | 2018 | 1734 | 0.320 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2023 | 3233 | 0.320 |
Why?
|
Decision Support Systems, Clinical | 1 | 2017 | 1162 | 0.320 |
Why?
|
Male | 52 | 2023 | 349022 | 0.320 |
Why?
|
Middle Aged | 40 | 2023 | 212863 | 0.310 |
Why?
|
Mitral Valve Insufficiency | 3 | 2022 | 1408 | 0.300 |
Why?
|
Risk Factors | 19 | 2023 | 71974 | 0.290 |
Why?
|
Heart Transplantation | 1 | 2020 | 3109 | 0.280 |
Why?
|
Catheter Ablation | 4 | 2022 | 2737 | 0.280 |
Why?
|
Cardiac Surgical Procedures | 2 | 2019 | 3517 | 0.280 |
Why?
|
Adipose Tissue | 4 | 2023 | 3280 | 0.280 |
Why?
|
Female | 46 | 2023 | 378853 | 0.270 |
Why?
|
Postoperative Complications | 3 | 2020 | 15194 | 0.260 |
Why?
|
Cardiovascular Diseases | 8 | 2023 | 15070 | 0.260 |
Why?
|
Prosthesis Design | 7 | 2020 | 2110 | 0.260 |
Why?
|
Risk Assessment | 14 | 2023 | 23294 | 0.250 |
Why?
|
Sex Factors | 1 | 2018 | 10398 | 0.240 |
Why?
|
Mitral Valve | 4 | 2022 | 1483 | 0.240 |
Why?
|
Humans | 66 | 2023 | 739398 | 0.240 |
Why?
|
Germany | 3 | 2015 | 853 | 0.240 |
Why?
|
Aged | 28 | 2023 | 162698 | 0.230 |
Why?
|
Prospective Studies | 15 | 2023 | 53037 | 0.220 |
Why?
|
Electrocardiography | 9 | 2019 | 6426 | 0.220 |
Why?
|
Prognosis | 9 | 2023 | 28901 | 0.210 |
Why?
|
Endoleak | 2 | 2013 | 101 | 0.210 |
Why?
|
HIV | 3 | 2023 | 1607 | 0.200 |
Why?
|
Aortography | 2 | 2014 | 429 | 0.200 |
Why?
|
Radiography, Interventional | 3 | 2013 | 1093 | 0.200 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2023 | 8977 | 0.200 |
Why?
|
High-Density Lipoproteins, Pre-beta | 1 | 2020 | 5 | 0.200 |
Why?
|
Aged, 80 and over | 14 | 2023 | 57650 | 0.190 |
Why?
|
Bradycardia | 1 | 2022 | 305 | 0.180 |
Why?
|
Reproducibility of Results | 12 | 2021 | 19811 | 0.180 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2020 | 280 | 0.180 |
Why?
|
Echocardiography, Transesophageal | 2 | 2017 | 1128 | 0.170 |
Why?
|
Prevalence | 4 | 2019 | 15153 | 0.170 |
Why?
|
Perfusion | 1 | 2023 | 1354 | 0.160 |
Why?
|
Nitroglycerin | 1 | 2019 | 325 | 0.160 |
Why?
|
Plasma | 1 | 2020 | 573 | 0.150 |
Why?
|
Obesity | 2 | 2023 | 12643 | 0.140 |
Why?
|
Myocardial Revascularization | 1 | 2020 | 841 | 0.140 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 808 | 0.140 |
Why?
|
Heart Ventricles | 2 | 2020 | 3799 | 0.140 |
Why?
|
Atrial Function, Right | 1 | 2015 | 33 | 0.140 |
Why?
|
Time Factors | 5 | 2019 | 40050 | 0.130 |
Why?
|
Registries | 3 | 2022 | 8039 | 0.130 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2020 | 371 | 0.130 |
Why?
|
North America | 1 | 2019 | 1249 | 0.130 |
Why?
|
Heart Function Tests | 1 | 2016 | 331 | 0.130 |
Why?
|
Adiposity | 3 | 2023 | 1801 | 0.130 |
Why?
|
Heart Injuries | 1 | 2017 | 210 | 0.130 |
Why?
|
Vasodilation | 1 | 2019 | 947 | 0.130 |
Why?
|
Pulmonary Veins | 1 | 2021 | 759 | 0.130 |
Why?
|
Early Diagnosis | 1 | 2020 | 1186 | 0.130 |
Why?
|
Cardiovascular System | 1 | 2022 | 830 | 0.130 |
Why?
|
Observer Variation | 3 | 2017 | 2589 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 2019 | 976 | 0.120 |
Why?
|
Fever | 1 | 2022 | 1607 | 0.120 |
Why?
|
Esophagus | 1 | 2020 | 1017 | 0.120 |
Why?
|
Comparative Effectiveness Research | 1 | 2019 | 679 | 0.120 |
Why?
|
Cardiac Imaging Techniques | 1 | 2016 | 269 | 0.120 |
Why?
|
Fluoroscopy | 2 | 2015 | 915 | 0.120 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2015 | 181 | 0.120 |
Why?
|
Tachycardia, Ventricular | 1 | 2022 | 1271 | 0.120 |
Why?
|
Vascular System Injuries | 1 | 2017 | 249 | 0.120 |
Why?
|
Heart Atria | 2 | 2020 | 1342 | 0.120 |
Why?
|
Workflow | 2 | 2015 | 831 | 0.110 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2014 | 364 | 0.110 |
Why?
|
Atrial Flutter | 1 | 2015 | 265 | 0.110 |
Why?
|
Exercise Test | 1 | 2020 | 2069 | 0.110 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2013 | 1178 | 0.110 |
Why?
|
Iopamidol | 1 | 2013 | 191 | 0.110 |
Why?
|
Automation | 1 | 2015 | 584 | 0.110 |
Why?
|
Retrospective Studies | 12 | 2021 | 76631 | 0.100 |
Why?
|
Myocardial Infarction | 3 | 2023 | 11668 | 0.100 |
Why?
|
Atrial Fibrillation | 2 | 2021 | 5003 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 3 | 2014 | 4035 | 0.100 |
Why?
|
Treatment Outcome | 10 | 2022 | 62693 | 0.100 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2017 | 591 | 0.100 |
Why?
|
Body Burden | 1 | 2011 | 158 | 0.100 |
Why?
|
ROC Curve | 1 | 2019 | 3526 | 0.100 |
Why?
|
Cardiology | 1 | 2022 | 1654 | 0.100 |
Why?
|
Software | 2 | 2015 | 4423 | 0.090 |
Why?
|
Preoperative Care | 3 | 2013 | 2238 | 0.090 |
Why?
|
Follow-Up Studies | 4 | 2021 | 38942 | 0.090 |
Why?
|
Contrast Media | 4 | 2020 | 5293 | 0.080 |
Why?
|
Catheters | 2 | 2022 | 419 | 0.080 |
Why?
|
Ventricular Function, Left | 2 | 2019 | 3620 | 0.080 |
Why?
|
Coronary Disease | 2 | 2014 | 6068 | 0.080 |
Why?
|
Angiography | 1 | 2013 | 1634 | 0.080 |
Why?
|
Inflammation | 2 | 2023 | 10534 | 0.070 |
Why?
|
Hemodynamics | 3 | 2022 | 4197 | 0.070 |
Why?
|
Radiometry | 1 | 2011 | 801 | 0.070 |
Why?
|
Heart Diseases | 1 | 2019 | 2782 | 0.070 |
Why?
|
Surgery, Computer-Assisted | 1 | 2013 | 1008 | 0.070 |
Why?
|
Adult | 11 | 2021 | 213394 | 0.060 |
Why?
|
Boston | 1 | 2018 | 9314 | 0.060 |
Why?
|
Health Status | 1 | 2018 | 4013 | 0.060 |
Why?
|
Acute Coronary Syndrome | 1 | 2018 | 2331 | 0.060 |
Why?
|
Stroke Volume | 1 | 2017 | 4941 | 0.060 |
Why?
|
Severity of Illness Index | 4 | 2014 | 15511 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2015 | 3344 | 0.060 |
Why?
|
Prosthesis Fitting | 2 | 2013 | 74 | 0.060 |
Why?
|
Heart Rate | 2 | 2011 | 4095 | 0.060 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2023 | 127 | 0.050 |
Why?
|
Macrophages | 1 | 2017 | 5631 | 0.050 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2012 | 1381 | 0.050 |
Why?
|
United States | 5 | 2023 | 69573 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 1 | 2011 | 2265 | 0.050 |
Why?
|
Endocardium | 1 | 2022 | 261 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6361 | 0.050 |
Why?
|
Incidence | 2 | 2021 | 20913 | 0.050 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2023 | 249 | 0.050 |
Why?
|
Body Mass Index | 1 | 2018 | 12655 | 0.050 |
Why?
|
Thorax | 1 | 2023 | 547 | 0.050 |
Why?
|
Administration, Sublingual | 1 | 2019 | 56 | 0.040 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2020 | 264 | 0.040 |
Why?
|
Clinical Competence | 1 | 2015 | 4671 | 0.040 |
Why?
|
Transdermal Patch | 1 | 2019 | 51 | 0.040 |
Why?
|
Tablets | 1 | 2019 | 148 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 12985 | 0.040 |
Why?
|
Eligibility Determination | 1 | 2022 | 403 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7626 | 0.040 |
Why?
|
Endovascular Procedures | 1 | 2012 | 1947 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2020 | 390 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2023 | 719 | 0.040 |
Why?
|
Quinolines | 1 | 2023 | 721 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2022 | 643 | 0.040 |
Why?
|
American Heart Association | 1 | 2022 | 1050 | 0.040 |
Why?
|
Linear Models | 3 | 2012 | 5948 | 0.040 |
Why?
|
Lipoproteins | 1 | 2022 | 880 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1116 | 0.040 |
Why?
|
Lipoproteins, LDL | 1 | 2020 | 626 | 0.040 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2017 | 68 | 0.040 |
Why?
|
Markov Chains | 1 | 2020 | 970 | 0.040 |
Why?
|
Mannans | 1 | 2017 | 63 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 2019 | 708 | 0.040 |
Why?
|
Mannose-Binding Lectins | 1 | 2017 | 100 | 0.040 |
Why?
|
Cicatrix | 1 | 2022 | 750 | 0.040 |
Why?
|
Aerosols | 1 | 2019 | 619 | 0.040 |
Why?
|
Quality of Life | 3 | 2022 | 12640 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2020 | 2270 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 2020 | 766 | 0.030 |
Why?
|
Gadolinium | 1 | 2020 | 951 | 0.030 |
Why?
|
Dextrans | 1 | 2017 | 590 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2017 | 5058 | 0.030 |
Why?
|
Young Adult | 2 | 2018 | 56255 | 0.030 |
Why?
|
Cohort Studies | 3 | 2022 | 40389 | 0.030 |
Why?
|
Temperature | 1 | 2021 | 2202 | 0.030 |
Why?
|
Time and Motion Studies | 1 | 2014 | 148 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2016 | 14740 | 0.030 |
Why?
|
Deep Sedation | 1 | 2015 | 121 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2020 | 35326 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 2017 | 544 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2017 | 586 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 919 | 0.030 |
Why?
|
Sinus of Valsalva | 1 | 2013 | 58 | 0.030 |
Why?
|
Radiation Dosage | 2 | 2012 | 1920 | 0.030 |
Why?
|
Coronary Circulation | 1 | 2019 | 1578 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 1510 | 0.030 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2015 | 484 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2023 | 21694 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2023 | 2583 | 0.030 |
Why?
|
Minority Groups | 1 | 2019 | 1197 | 0.030 |
Why?
|
Iliac Artery | 1 | 2013 | 363 | 0.030 |
Why?
|
Angioplasty | 1 | 2014 | 363 | 0.030 |
Why?
|
Iohexol | 1 | 2012 | 196 | 0.030 |
Why?
|
Patient Selection | 2 | 2013 | 4211 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2023 | 8605 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4522 | 0.020 |
Why?
|
Aorta, Abdominal | 1 | 2013 | 645 | 0.020 |
Why?
|
Adolescent | 1 | 2018 | 85405 | 0.020 |
Why?
|
Therapy, Computer-Assisted | 1 | 2012 | 274 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3584 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2023 | 11985 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 24714 | 0.020 |
Why?
|
Femoral Artery | 1 | 2013 | 841 | 0.020 |
Why?
|
Aorta | 1 | 2017 | 2048 | 0.020 |
Why?
|
Propofol | 1 | 2015 | 626 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2019 | 2261 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2017 | 2026 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2020 | 3609 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2013 | 884 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2013 | 918 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5462 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2864 | 0.020 |
Why?
|
Hypnotics and Sedatives | 1 | 2015 | 1158 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6452 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3583 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2687 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2022 | 12948 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 2013 | 1184 | 0.020 |
Why?
|
Models, Cardiovascular | 1 | 2011 | 997 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2012 | 1078 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3510 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2017 | 3454 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2011 | 2974 | 0.020 |
Why?
|
Phenotype | 1 | 2022 | 16301 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3606 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2011 | 2504 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 9812 | 0.010 |
Why?
|
Computer Simulation | 1 | 2011 | 6237 | 0.010 |
Why?
|
Algorithms | 1 | 2015 | 13872 | 0.010 |
Why?
|